S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NAUT Nautilus Biotechnology Inc

2.73

-0.05 (-1.80%)

Last Updated: 09:31:02

Delayed by 15 minutes

Nautilus Biotechnology GAAP EPS of -$0.13 in-line

To read the full story on Seeking Alpha, click here.

Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Nautilus Biotechnology Charts.

Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Nautilus Biotechnology Charts.

Nautilus Biotechnology Inc News

Nautilus Biotechnology Reports First Quarter 2024 Financial Results
Tuesday 30 April 2024 (2 days ago) • GlobeNewswire Inc.

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

More Nautilus Biotechnology Inc News Articles

Atacama Resources (PK)

Global Developments (PK)

NaturalShrimp (QB)

Mullen Automotive

Verb Technology

International Star (PK)

Federal Home Loan Mortgage (QB)

FBEC Worldwide (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

NioCorp Developments

Globestar Therapeutics (PK)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions